GATT Technologies BV
- Country
- 🇳🇱Netherlands
- Ownership
- Holding, Subsidiary
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.gatt-tech.com
Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery
- Conditions
- Gallbladder DiseasesHemorrhage, SurgicalIntraoperative BleedingLiver Diseases
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- GATT Technologies BV
- Target Recruit Count
- 50
- Registration Number
- NCT05900037
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
🇺🇸Capital Health, Pennington, New Jersey, United States
GATT-Patch Versus TachoSil in Liver Surgery
- Conditions
- Hemorrhage, SurgicalLiver DiseasesIntraoperative Bleeding
- Interventions
- Device: GATT-Patch
- First Posted Date
- 2022-05-23
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- GATT Technologies BV
- Target Recruit Count
- 131
- Registration Number
- NCT05385952
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
🇺🇸Rutgers University, Newark, New Jersey, United States
Clinical Safety and Performance of GATT-Patch in Open Liver Surgery
- Conditions
- Hemorrhage, Surgical
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- GATT Technologies BV
- Target Recruit Count
- 47
- Registration Number
- NCT04819945
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
🇳🇱Erasmus University Medical Center, Rotterdam, Zuid-Holland, Netherlands
🇳🇱University Medical Center Groningen, Groningen, Netherlands